T. Rowe Price Associates’s ASP Isotopes ASPI Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPI
ECA
RIM
ETC
AIC
T. Rowe Price Associates's ASPI Position: Q2 2026 in Review
T. Rowe Price Associates increased its ASP Isotopes (ASPI) stake by 20% in Q2 2026, buying an estimated $95.8K and bringing the position to 96,913 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #2533.
T. Rowe Price Associates first reported a position in ASPI in Q2 2024 and has held it in 9 quarters since. The position peaked at $10.1M in Q3 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.
- T. Rowe Price Associates held 96,913 shares of ASP Isotopes worth $603K as of Q2 2026.
- T. Rowe Price Associates bought 16,272 ASP Isotopes shares in Q2 2026, an estimated $95.8K.
- ASP Isotopes made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2533 holding.
- T. Rowe Price Associates first reported a position in ASP Isotopes in Q2 2024 and has held it in 9 quarters since.
- T. Rowe Price Associates's ASP Isotopes position peaked at $10.1M in Q3 2025.
- 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.